The Patent Finder

Antares Pharma, Ipl, AG

Also on record
Records under this name other than patents Antares Pharma, Ipl, AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Antares Pharma, Ipl, AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,980,309Transdermal Testosterone Formulation for Minimizing Skin Residues
Term ended
Term ended May 2, 2026 · Medium confidence
Term endedTerm ended May 2, 2026Medium confidence
US 8,647,665Methods of treating hot flashes with formulations for transdermal or transmucosal application
Lapsed on the fee record
Ended Feb 11, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 11, 2026USPTO record
US 9,682,087Nestorone®/estradiol transdermal gel
Formerly held
Lapsed on the fee record
Ended Jun 20, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 20, 2025USPTO record
US 7,335,379Transdermal Pharmaceutical Formulation for Minimizing Skin Residues
Term ended
Ended no later than Oct 6, 2024 · Medium confidence
Term endedEnded no later than Oct 6, 2024Medium confidence
US 8,268,346Methods of treating hot flashes with formulations for transdermal or transmucosal application
Lapsed on the fee record
Ended Sep 18, 2024 · USPTO record
Lapsed on the fee recordEnded Sep 18, 2024USPTO record
US 8,980,290Transdermal compositions for anticholinergic agents
Term ended
Term ended Aug 12, 2022 · USPTO record
Term endedTerm ended Aug 12, 2022USPTO record
US 7,198,801Formulations for Transdermal or Transmucosal Application
Term ended
Ended no later than Jun 25, 2022 · Medium confidence
Term endedEnded no later than Jun 25, 2022Medium confidence
US 7,470,433Formulations for Transdermal or Transmucosal Application
Term ended
Ended no later than Aug 3, 2021 · Medium confidence
Term endedEnded no later than Aug 3, 2021Medium confidence
US 8,652,491Transdermal compositions for anticholinergic agents
Term ended
Ended no later than Aug 3, 2021 · USPTO record
Term endedEnded no later than Aug 3, 2021USPTO record
US 8,338,400Methods and apparatus for transdermal or transmucosal application of testosterone
Lapsed on the fee record
Ended Dec 25, 2020 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2020USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited